In IBD, key signaling pathways such as NF-κB and NLRP3 inflammasome are widely recognized as central molecular hubs driving the amplification of persistent inflammation and hindering the intestinal epithelial barrier’s repair [123,124]. This evidence concerns the gene NLRP3 and inflammatory bowel disease.